CIK: 1662119 - Address: C/O Zai Lab Limited, 314 Main Street, 4Th Floor, Suite 100, Cambridge, MA 02142
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/14/24 16:18
8/12/24
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaS-5016.200-3-1320D
4/5/24 17:47
4/3/24
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaM.d8615.90053024D
4/5/24 17:47
4/4/24
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaS.d-3115.670-2-824D
3/19/24 16:12
3/15/24
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaS-4818.860-3-1120D
1/3/24 19:26
12/29/23
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaM.d00.0004223D
1/3/24 19:26
1/2/24
ZLABZai Lab LtdE9HealthDrugPharmaceutical PreparationsAmado RafaelMAOSee RemaS.d-50926.300-19-4623D
8/2/22 17:40
8/2/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAmado RafaelCAOEVP of RS-2411.970-20540D
7/6/22 16:16
7/5/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAmado RafaelCAOEVP of RS-2311.440-20542D
6/22/22 16:47
6/21/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAmado RafaelCAOEVP of RS-2211.180-20544D
5/19/22 17:40
5/19/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAmado RafaelCAOEVP of RS-857.400-12-2546D
3/17/22 17:59
3/15/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAmado RafaelCAOEVP of RS-407.710-5-2320D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact